Advertisement
News
Subscribe to MDT Magazine News

Steris fiscal 3Q profit falls 47 percent

February 8, 2011 6:45 am | by The Associated Press | Comments

Medical products maker Steris Corp. said Tuesday its fiscal third-quarter net income slid 47 percent mainly due to a pretax charge of nearly $20 million for a class-action litigation settlement.The Mentor, Ohio, company earned $21.8 million, or 36 cents per share, in the quarter that ended Dec....

The Villages Charter School Receives Donation From Praxis EMR

February 8, 2011 5:35 am | by Bio-Medicine.Org | Comments

THE VILLAGES, Fla., Feb. 8, 2011 /- Today, The Villages Charter School announced receipt of supplies and equipment donated by Praxis: The Template-Free EMR. Praxis made the donation soon after learning of the school's plans to begin using its electronic medical records system as part of...

TOPICS:

Symmetry Medical to Host Investor Breakfast on February 17, 2011

February 8, 2011 5:35 am | by Bio-Medicine.Org | Comments

WARSAW, Ind., Feb. 8, 2011 /- Symmetry Medical Inc. (NYSE: SMA ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that the Company will host an Investor Breakfast on Thursday, February 17, 2011 at 7:30 a.m....

TOPICS:
Advertisement

ASU benefit encourages community to have a HeArt

February 8, 2011 5:35 am | by Arizona State University | Comments

ASU's College of Nursing & Health Innovation is hosting the inaugural "Have a HeArt" benefit to help fund the university's four non-profit clinics around the Valley.read more

TOPICS:

One-Year European Registry Data Released for Popliteal Stenting With SUPERA®

February 8, 2011 5:34 am | by Bio-Medicine.Org | Comments

LEIPZIG, Germany, Feb. 8, 2011 /- Data from the Leipzig Registry tracking the results of patients treated with the SUPERA® stent for peripheral arterial disease (PAD) of the popliteal artery were reported during the recent 2011 Leipzig Interventional Course (LINC).  The SUPERA...

TOPICS:

Hologic Targets Women's Health Professionals at ECR 2011

February 8, 2011 5:34 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., Feb. 8, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on new,...

TOPICS:

College of Nursing chosen as outreach partner for Ariz.

February 8, 2011 5:34 am | by Arizona State University | Comments

The ASU College of Nursing & Health Innovation has been selected as the National Institute of Mental Health Outreach Partner for 2011 through 2013 for the state of Arizona.read more

TOPICS:

Public Workshop - Center for Devices and Radiological Health's Innovation Initiative, March 15, 2011

February 8, 2011 4:31 am | by U.S. Food & Drug Administration | Comments

The purpose of the public workshop is to solicit public feedback on select actions outlined in CDRH's Medical Device Innovation Initiative (report). FDA is seeking input on a number of identified challenges associated with incentivizing innovation, and...

TOPICS:
Advertisement

CDRH Medical Device Innovation Initiative

February 8, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

CDRH recognizes that transformative innovative devices typically present new scientific and regulatory challenges. The Innovation Initiative supports the development of innovative products by addressing some of the barriers that can impede a product's...

TOPICS:

Kindred Healthcare buying RehabCare for $900M

February 8, 2011 3:45 am | by MARLEY SEAMAN - AP Health Writer - Associated Press | Comments

Kindred Healthcare, a provider of acute care hospital and inpatient rehabilitation services, said Tuesday it has agreed to buy rival RehabCare Group for about $900 million in cash and stock.The deal would combine Kindred's contract rehabilitation service business, which has about 550 customers,...

Summary Box: Kindred Healthcare buys RehabCare

February 8, 2011 3:45 am | by The Associated Press | Comments

THE DEAL: Kindred Healthcare Inc. plans to buy RehabCare Group Inc. for about $900 million, or $35 per share, in cash and stock. The deal also includes Kindred assuming about $400 million in debt.MORE CONTRACTS: Kindred is the larger of the two companies. They both operate long-term acute care...

Henry Schein to Webcast Fourth Quarter 2010 Conference Call Tuesday, February 22, at 10:00 a.m. EST

February 8, 2011 3:33 am | by Bio-Medicine.Org | Comments

MELVILLE, N.Y., Feb. 8, 2011 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that it will release its fourth quarter 2010 financial results before the stock market opens on Tuesday, February...

TOPICS:

NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics

February 8, 2011 3:33 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Feb. 8, 2011 /- NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited to present the results of a key QTinno® performance study at the National Scientific Meeting of the...

TOPICS:

ICBU Announces Corporate Reorganization and Business Plan

February 8, 2011 3:32 am | by Bio-Medicine.Org | Comments

TAMPA, Fla., Feb. 8, 2011 /- In the Third Quarter of 2010, The Board of Directors of International Coastal Biofuels (OTC MARKETS: ICBU) has elected to change the company name to iMD Companies, Inc. In addition, a new management team will take control of ICBU with the objective of...

TOPICS:

Adeona's Alzheimer's Disease Pivotal Clinical Study Results Abstract Accepted for Presentation at the American Academy of Neurology's 63rd Annual Meeting

February 8, 2011 2:33 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Feb. 8, 2011 /- Adeona Pharmaceuticals, Inc. (Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that an abstract on the Company's pivotal clinical trial of its zinc and cysteine-based product candidate being...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading